Alcon Net Income 2019-2024 | ALC
Alcon annual/quarterly net income history and growth rate from 2019 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Alcon net income for the quarter ending June 30, 2024 was $0.223B, a 31.95% increase year-over-year.
- Alcon net income for the twelve months ending June 30, 2024 was $1.102B, a 204.42% increase year-over-year.
- Alcon annual net income for 2023 was $0.974B, a 190.75% increase from 2022.
- Alcon annual net income for 2022 was $0.335B, a 10.9% decline from 2021.
- Alcon annual net income for 2021 was $0.376B, a 170.81% decline from 2020.
| Alcon Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $974 |
| 2022 | $335 |
| 2021 | $376 |
| 2020 | $-531 |
| 2019 | $-656 |
| 2018 | $-227 |
| Alcon Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-06-30 | $223 |
| 2024-03-31 | $248 |
| 2023-12-31 | $427 |
| 2023-09-30 | $204 |
| 2023-06-30 | $169 |
| 2023-03-31 | $174 |
| 2022-12-31 | $-97 |
| 2022-09-30 | $116 |
| 2022-06-30 | $148 |
| 2022-03-31 | $168 |
| 2021-12-31 | $139 |
| 2021-09-30 | $2 |
| 2021-06-30 | $151 |
| 2021-03-31 | $84 |
| 2020-12-31 | $95 |
| 2020-09-30 | $-147 |
| 2020-06-30 | $-422 |
| 2020-03-31 | $-57 |
| 2019-12-31 | $-91 |
| 2019-09-30 | $-66 |
| 2019-06-30 | $-390 |
| 2019-03-31 | $-109 |
| 2018-12-31 | |
| 2018-09-30 | $-207 |
| 2018-06-30 | $15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $47.978B | $9.455B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.667B | 27.41 |
| Intuitive Surgical (ISRG) | United States | $171.263B | 96.97 |
| IQVIA Holdings (IQV) | United States | $41.900B | 23.74 |
| Edwards Lifesciences (EW) | United States | $39.451B | 25.29 |
| IDEXX Laboratories (IDXX) | United States | $39.315B | 47.29 |
| DexCom (DXCM) | United States | $27.294B | 38.92 |
| STERIS (STE) | Ireland | $22.783B | 26.58 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.950B | 0.00 |
| Waters (WAT) | United States | $20.926B | 31.20 |
| Hologic (HOLX) | United States | $18.638B | 20.26 |
| Sysmex ADR (SSMXY) | Japan | $12.525B | 39.28 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.147B | 13.62 |
| Teleflex (TFX) | United States | $11.269B | 17.52 |
| Globus Medical (GMED) | United States | $9.568B | 26.77 |
| Penumbra (PEN) | United States | $7.564B | 78.52 |
| Masimo (MASI) | United States | $7.385B | 39.55 |
| Glaukos (GKOS) | United States | $7.197B | 0.00 |
| TransMedics (TMDX) | United States | $4.636B | 198.53 |
| Integer Holdings (ITGR) | United States | $4.329B | 25.32 |
| PROCEPT BioRobotics (PRCT) | United States | $3.773B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.923B | 17.14 |
| Tandem Diabetes Care (TNDM) | United States | $2.735B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.599B | 16.17 |
| Elekta AB (EKTAY) | Sweden | $2.596B | 21.15 |
| Veracyte (VCYT) | United States | $2.523B | 156.38 |
| Inari Medical (NARI) | United States | $2.443B | 0.00 |
| RxSight (RXST) | United States | $1.809B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.319B | 6.01 |
| Artivion (AORT) | United States | $1.108B | 101.69 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.066B | 19.02 |
| OPKO Health (OPK) | United States | $1.039B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.979B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.771B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.723B | 18.25 |
| IRadimed (IRMD) | United States | $0.631B | 34.12 |
| OrthoPediatrics (KIDS) | United States | $0.628B | 0.00 |
| SiBone (SIBN) | United States | $0.612B | 0.00 |
| AxoGen (AXGN) | United States | $0.599B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.584B | 0.00 |
| Paragon 28 (FNA) | United States | $0.491B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.469B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.343B | 10.47 |
| Treace Medical Concepts (TMCI) | United States | $0.332B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.309B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.292B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.248B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.244B | 0.00 |
| Inogen (INGN) | United States | $0.216B | 0.00 |
| NeuroPace (NPCE) | United States | $0.199B | 0.00 |
| Accuray (ARAY) | United States | $0.192B | 0.00 |
| CVRx (CVRX) | United States | $0.191B | 0.00 |
| Nevro (NVRO) | United States | $0.185B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.185B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.175B | 12.25 |
| Alpha Tau Medical (DRTS) | Israel | $0.159B | 0.00 |
| 908 Devices (MASS) | United States | $0.121B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.120B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.119B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.103B | 15.34 |
| EDAP TMS S.A (EDAP) | France | $0.098B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.066B | 0.00 |
| Envoy Medical (COCH) | United States | $0.065B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.063B | 0.00 |
| LENSAR (LNSR) | United States | $0.052B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.046B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.044B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.043B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| DarioHealth (DRIO) | United States | $0.034B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.034B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.032B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.028B | 0.00 |
| Neuronetics (STIM) | United States | $0.026B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.019B | 0.00 |
| Spectral AI (MDAI) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |